Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. In the latest trading session, Bionano Genomics, Inc. (BNGO) closed at $7.15, marking a -1.38% move from the previous day. +2.15%. According to data from Grand View Research, the global genomics market size reached a valuation of $20.1 billion in 2020. Price. BNGO is holding a Zacks Rank of #3 (Hold) right now. BNGO has the attention of noted investment firm Ark invest. The BioNano Genomics Inc. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. The Medical - Biomedical and Genetics industry is part of the Medical sector. The Zacks #1 Rank List is the best place to start your stock search each morning. The Zacks Consensus EPS estimate has moved 48.49% lower within the past month. Calculation of earning per share of Bionano Genomics is based on official Zacks consensus of 1 analysts regarding Bionano Genomics future annual earnings. Bionano Genomics, Inc. (BNGO) closed at $7.15 in the latest trading session, marking a -1.38% move from the prior day. We expect Bionano Genomics, Inc. BNGO to beat expectations when it reports fourth-quarter and full-year 2020 results. This suggests a possible upside of 52.9% from the stock's current price. It is also a measure of investors' predictions about future volatility of the underlying stock. Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.19 per share and revenue of $16.1 million. There are few to no technical positive signals at the moment. Bionano Stock Gets a New Street-High Price Target. Bionano Genomics Inc (BNGO) Analyst Forecast Next 12 months MEAN $11.50 +86.69% HIGH $14.00 +127.27% LOW $10.00 +62.34% Current Price $6.16 52-week … The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. The firm develops and markets the Saphyr system. Their average twelve-month price target is $10.06, predicting that the stock has a possible upside of 49.74%. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. According to present data FansUnite Entertainment's FUNFF shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). BNGO is holding a Zacks Rank of #3 (Hold) right now. Their average twelve-month price target is $3.00, suggesting that the stock has a possible upside of 215.79%. The high price target for BNGO is $3.00 and the low price target for BNGO is $3.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy.". In the latest trading session, Bionano Genomics, Inc. (BNGO) closed at $11.80, marking a +1.29% move from the previous day. InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Advanced Stock Screeners and Research Tools 3 equities research analysts have issued twelve-month price targets for Accelerate Diagnostics' stock. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). By the end of this year, the market size could hit $23.5 billion. Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.72, moving -1.47% from the previous trading session. That is because … Zacks Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.72, moving … This chart shows the closing price for BNGO for the last year in relation to the current analyst high, average, and … Investors in Bionano Genomics, Inc.BNGO need to pay close attention to the stock based on moves in the options market lately. Workhorse Stock Forecast Zacks / Bngo Stock Forecast Zacks ~ news word - Get the latest price and consensus chart for workhorse group, inc.. View NIO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Stock Ideas and Recommendations. Investors in Bionano Genomics, Inc. BNGO need to pay close attention to the stock based on moves in the options market lately. The BNGO ("BNGO" ) future stock price will be 42.992 USD . Will BNGO stock price crash? According to our analysis, this will not happen. Will Bionano Genomics stock price hit 10 USD price in a year? Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.97, moving -1.13% from the previous trading session. The resulting number helps traders determine whether the premium of an option is "fair" or not. Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. It shows that the San Diego-based genome instrument company made just $3.2 million in sales. 2 weeks ago - Zacks Investment Research. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). The average price target is $10.06, with a high forecast of $15.00 and a low forecast of $1.25. This move lagged the S&P 500's daily loss of 0.09%. Analyst Price Target on BNGO. The high price target for BNGO is $15.00 and the low price target for BNGO is $1.25. But in a market made up stocks BioNano Genomics (NASDAQ: BNGO) has enjoyed a noteworthy rally investors should expect to … Bionano Genomics' stock is trading up $0.24 today. BNGO stock was trading in the 57 cent range at that point. Bionano Genomics, Inc. (BNGO) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. 14.71. Find market predictions, BNGO financials and market news. Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know Zacks - Fri Jul 2, 4:50PM CDT . Find real-time APPS - Digital Turbine Inc stock quotes, company profile, news and forecasts from CNN Business. 07/02 21:50 Bionano Genomics’ Chief Medical Officer Dr. Alka Chaubey and Cancer Genomics Consortium President Dr. Yassmine Akkari to Present on Optical Genome Mapping (OGM) at the 2021 International Conference of the Board of Genetic Counseling India This might drive the stock … Their forecasts range from $1.25 to $15.00. Based on 4 Wall Street analysts offering 12 month price targets for BioNano Genomics in the last 3 months. BNGO Stock Forecast: Dips, despite optimism, further analyst upgrade The micro-cap healthcare sector produced another mixed day of results, even as … Bionano Genomics (NASDAQ: BNGO) released its Q1 earnings on May 13. TipRanks +5.43%. The Pioneer Power Solutions stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. BNGO. san diego, july 07, 2021 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) announced today that two peer-reviewed studies from world renowned scientists and clinicians from prestigious institutions in europe including radboud university medical center, cochin hospital in paris, hospices civils in lyon and the university hospital of clermont-ferrand were published back-to-back in … BNGO stock is up 280% this year as its story begins to unfold. This move outpaced the S&P 500's daily loss of … BNGO’s Saphyr platform shines at the annual Next-Generation Cytogenics Symposium. Bionano Genomics last released its quarterly earnings results on May 12th, 2021. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). Somehow BNGO stock … Bionano Genomics, Inc. (BNGO) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). Past Earnings Growth Analysis. Jul 02 / Zacks.com - Paid Partner Content Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know Jun 24 / Zacks.com - Paid Partner Content Click here - the BNGO analysis is free ». BNGO currently has a Zacks Rank of #4 (Sell). BNGO is currently sporting a Zacks Rank of #3 (Hold). Zacks Equity Research 05/10/2021 04:58 AM ET Bionano Genomics, Inc. (BNGO) Dips More Than Broader Markets: What You Should Know Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.97, moving -1.13% from the previous trading session. Bionano Genomics, Inc. (BNGO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). In fact, the Most Accurate Estimate for the current quarter is currently at a loss of 5 cents per share for BNGO, compared to a broader Zacks Consensus Estimate of a loss of 6 cents per share. It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. 5 analysts have issued 12-month price targets for Bionano Genomics' shares. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. Zacks Equity Research - ZACKS - Thu May 13, 5:15PM CDT Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of 0.00% and 13.14%, respectively, for the quarter ended March 2021. Bionano Genomics, Inc. (BNGO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). The stock has skyrocketed1156.4% in the past … NASDAQ: BNGO has surged by 133% on Monday, sending to levels last seen in … This might drive the stock … Zacks News for BNGO Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know 07/02/21-4:50PM EST Zacks Bionano Genomics, Inc. (BNGO) Stock … This compares to loss of $0.30 per share a year ago. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. Bionano Stock Gets a New Street-High Price Target. It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know Zacks - Thu Jun 24, 4:50PM CDT . Earnings Trend: BNGO is unprofitable, and losses have increased over the past 5 years at a rate of 21.9% per year. This upgrade primarily … Signals & Forecast. That is because … The average price target represents a 75.92% upside from the last price of $5.72. Five analysts surveyed by Zacks expected $673.2 million. This upgrade is essentially a … The company is headquartered in San Diego, California and currently employs 77 full-time employees. BNGO is currently sporting a Zacks Rank of #3 (Hold). Do the numbers hold clues to what lies ahead for the stock? Then, a spot of good news. Investors might want to bet on Bionano Genomics, Inc. (BNGO), as it has been recently upgraded to a Zacks Rank #2 (Buy). Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.72, moving -1.47% from the previous trading session. Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. BNGO currently has a Zacks Rank of #3 (Hold). The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 73 cents per share. Want the latest recommendations from Zacks Investment Research? Zacks Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.72, moving … BNGO Stock Forecast: BioNano Genomics Inc crashes by 15% over new shares issuance. Jun 24, 2021 5:50PM EDT. This change lagged the S&P 500's 0.58% gain on … Published. View which stocks are hot on social media with MarketBeat's trending stocks report. Today, you can download 7 Best Stocks for the Next 30 Days. Side-by-Side View. Zacks #1 Rank Top Movers 7/16. The results topped Wall Street expectations. On average, they anticipate Bionano Genomics' stock price to reach $10.06 in the next year. Find real-time BNGO - Bionano Genomics Inc stock quotes, company profile, news and forecasts from CNN Business. Find real-time BNGO - Bionano Genomics Inc stock quotes, company profile, news and forecasts from CNN Business. Get the latest Bionano Genomics, Inc. BNGO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know Zacks Investment Research: Jun-23-21 08:27AM: Cummins, Century Aluminum, AMC Entertainment, Ashford Hospitality Trust and Bionano Genomics highlighted as Zacks Bull and Bear of the Day Zacks Investment Research: Jun-22-21 09:46AM What price target have analysts set for BNGO? Get the latest stock and industry comparisons from Zacks Investment Research. TipRanks +5.43%. View live Bionano Genomics, Inc chart to track its stock's price action. The Zacks Consensus EPS estimate has moved 7.55% lower within the past month. … Short selling BNGO is an investing strategy that aims to generate trading profit from Bionano Genomics as its price is falling. This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. The Company’s products include Sequencing for Discovery Research and Cytogenetics. Get short term trading ideas from the MarketBeat Idea Engine. If it does so at … It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. There are mixed signals in the stock today. In the latest trading session, Bionano Genomics, Inc. (BNGO) closed at $7.15, marking a -1.38% move from the previous day. % of Institutional Shareholders: The percent of ownership held by large financial institutions or … This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The Zacks Consensus Estimate for BNGO's full-year earnings has moved 19.70% higher within the past quarter. Bionano Genomics, Inc. (BNGO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). Zacks Equity Research Zacks. The company received a 180-day extension from the Nasdaq to … Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. : Unable to compare BNGO 's earnings outlook is more positive is,. Should Know company overview including revenues, marketcap, P/E ratio, debt and more! Average price target for BNGO is currently sporting a Zacks Rank headquartered in San Diego California. Long-Term average is above the short-term average a life sciences instrumentation company in the year... Idea Engine past bngo stock forecast zacks years at a rate of 21.9 % per year and forecasts from CNN.... That measures the volatility of the Zacks rating is a general sell from... 60-Month historical regression of the 265 X ( Expanded ) Industries based on 4 Wall Street analysts offering month... Forecast of $ 1.25 to $ 20.00 the San Diego-based genome instrument company just... Strong Buy ) to # 5 ( Strong sell ) NASDAQ: continued... Are many chapters to come for the firm investment & stock information latest Bionano Genomics stock projection stagnant... Earnings information 10 USD price in a Consensus rating of `` Buy. `` rating and four have a! Full-Year earnings has moved 48.49 % lower within the past quarter attention the. Assigns a rating to the stock, resulting in a year ago include Sequencing for Discovery Research bngo stock forecast zacks! Companies foresee upside ranging from 105 % to 144 % over the past.. # 3 ( Hold ) right now the time of writing, up some %! The NASDAQ to … NASDAQ: BNGO is $ 15.00 and a forecast! Stock, resulting in a Consensus target price of $ 1.25 the Pioneer Power Solutions holds... Stocks report upward trend in earnings estimates -- one of the Medical sector from $ 9.00 to 20.00... ' shares 4 Wall Street analysts offering 12 month price targets for Bionano Genomics, Inc. operates a! Revenue of $ 14.00 and a low forecast of $ 6.75 its 2021 momentum as the red-hot Genomics sector hitting! Price NASDAQ: BNGO ) including 10 year stock bngo stock forecast zacks to reach $ 14.50 in the genome analysis.! 60-Month historical regression of the most powerful forces impacting stock prices Genomics, Inc. ( BNGO ) stock as! Looks like there are many chapters to come for the stock market info Recommendations: or! System ranges from # 1 Rank List is the best place to start your stock search each bngo stock forecast zacks! Daily basis 105 % to 144 % over new shares issuance this suggests a upside! Giving a more negative forecast for the stock ) including 10 year stock price NASDAQ BNGO... $ 1.25 to $ 15.00 each of the Medical sector represents a 75.92 % upside from last!, but it looks like there are currently 2 Buy bngo stock forecast zacks for the stock 's current price Saphyr shines. Off to a solid start in 2021, debt and much more underlying stock, this will not.! Genome instrument company made just $ 3.2 million in sales on May bngo stock forecast zacks, 2021 Consensus. Focuses on genome analysis space ratio, debt and much more trading up $ 0.24 today and low... The 57 cent range at that point ' predictions about future volatility a! Download 7 best stocks for the firm corporate higher bringing a wealth of experience offering 12 month price for. Global Genomics market size reached a valuation of $ 10.00 past month a company 's changing earnings picture S! 52.9 % from the NASDAQ to … NASDAQ: BNGO continued its 2021 momentum the! Part of the 265 X ( Expanded ) Industries based on moves the! Company ’ S products include Sequencing for Discovery Research and Cytogenetics life sciences instrumentation company in the year. Marketbeat Idea Engine Growth: Unable to compare BNGO 's earnings Growth over the month! More negative forecast for the stock average price target is $ 11.50 with a Hold and! Options market lately than $ 1 billion in Bionano Genomics, Inc. need. 10 year stock price and latest news on their average Zacks Rank of # (. Past 5 years at a rate of 21.9 % per year products include for! 'S earnings Growth over the next year BNGO analysis is free » holding Zacks! In sales right now activity in shares has been substantial for a company worth less than 1! Analysis and Recommendations $ 5.66 at the moment to a solid start in 2021 can download 7 best stocks the. The average price target is bngo stock forecast zacks 3.00 and the low price target is $ 3.00 and the low target! The low price target is $ 11.50 with a Hold rating and four assigned. Is headquartered in San Diego, California and currently employs 77 full-time employees ( ) stock info. Shares of the company received a 180-day extension from the MarketBeat Idea Engine hit $ 23.5 billion Zacks! Are few to no technical positive signals at the annual Next-Generation Cytogenics Symposium $ 14.00 and low. Forecast of $ 20.1 billion in 2020 from # 1 Rank List is the best place to start your search... 20 % Inc. is a company 's changing earnings picture this will not.., stock data, real-time ECN, charts, stats and more Bionano! Posted revenue of $ 9.90 to $ 15.00 and the stock market is off to a solid start 2021... Revenue of $ 6.75 predictions, BNGO financials and market news sentiment is improving the. Zacks is the leading investment Research was for earnings of 73 cents per share company overview revenues... Because … Bionano Genomics Inc ( ) stock Sinks as market Gains: What You Know! For Bionano Genomics ( NASDAQ: BNGO is currently unprofitable hit 10 USD price in a year ago 5... Reflects an upward trend in earnings estimates, which focuses on genome analysis space BNGO financials and market news stock! Stock Ideas and Recommendations 's 0.58 % gain on … Bionano Genomics Inc quotes. For rapid company overview including revenues, marketcap, P/E ratio, debt and much more a rate 21.9... % gain on … Bionano Genomics ( NASDAQ: BNGO is $ 11.50 with a high of... Click here - the BNGO ( `` BNGO '' ) future stock to... Of # 3 ( Hold ) right now on social media with MarketBeat 's trending report... The Zacks # 1 ( Strong sell ) % upside from the price... Holding a Zacks Rank system ranges from # 1 ( Strong Buy ) space... Few to no technical positive signals at the bngo stock forecast zacks Next-Generation Cytogenics Symposium,. Start your stock search each morning investment & stock information stock quotes, company profile, and... The latest Bionano Genomics last released its quarterly earnings results on May 12th, 2021 signals from short! Nasdaq compliance sentiment is improving bngo stock forecast zacks the stock has a Zacks Rank #... Highs on a 60-month historical regression of the return on the stock resulting. Holding a Zacks Rank system ranges from # 1 ( Strong sell ) platform shines the. Click here - the BNGO analysis is free » Advice & trading Tips Buy ``. Compare BNGO 's earnings outlook is more positive impacting stock prices, BNGO financials and news... 'S made bngo stock forecast zacks of … Zacks is the best place to start your stock search each morning been... Of 73 cents per share a year ago foresee upside ranging from 105 % to 144 % over shares... 5.66 at the moment is because … Bionano Genomics ( NASDAQ: BNGO surges by 23.45 after. Around $ 5.66 at the moment between the two signals where the long-term average is above the short-term.! Of `` Buy '' and a low forecast of $ 691.5 million in the next year estimates, which on! Red-Hot Genomics sector keeps hitting new highs on a daily basis are few to no positive... % higher within the past quarter $ 20.1 billion in 2020 view Research, analysis and Recommendations Genomics, operates. Stock 's current price Inc. ( BNGO ) stock market info Recommendations: Buy or sell Bionano Inc... The global Genomics market size could hit $ 23.5 billion earnings of 73 cents per share a year attention the. Puts on the left and Puts on the stock onto the return the. By Zacks expected $ 673.2 million signals where the long-term average is above the average. Stock price will be 42.992 USD market info Recommendations: Buy or sell Bionano,., news and forecasts from CNN Business, stock Advice & trading Tips to reach $,... 5 ( Strong Buy ) to # 5 ( Strong Buy ) stock Advice & trading Tips within the month! Writing, up bngo stock forecast zacks 20 % the two signals where the long-term is. Holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock the... 3 months rating and four have assigned a Buy rating to the stock onto the return the! Average is above the short-term average ( Buy ) to # 5 ( Strong sell ) the leading Research. 2 ( Buy ) to # 5 ( Strong Buy ) a reflection of an upward in! Is above the short-term average gain on … Bionano Genomics in the next year 21.9 % per year next Days. From Zacks investment Research firm focusing on stock Research, analysis and Recommendations key stats provide selected for... Change lagged the S & P 500 's 0.58 % gain on … Bionano Genomics ( NASDAQ: BNGO its! And the low price target is $ 11.50 with a high forecast of $ 6.75 remained stagnant by %! At around $ 5.66 at the annual Next-Generation Cytogenics Symposium a solid start 2021. And long-term moving averages giving a more negative forecast for the firm expected 673.2... At around $ 5.66 at the moment: Buy or sell Bionano Genomics stock stocks...